Edition:
United States

China Meheco Co Ltd (600056.SS)

600056.SS on Shanghai Stock Exchange

21.85CNY
22 Feb 2018
Change (% chg)

¥0.02 (+0.09%)
Prev Close
¥21.83
Open
¥22.40
Day's High
¥22.40
Day's Low
¥21.78
Volume
6,359,120
Avg. Vol
7,846,648
52-wk High
¥29.26
52-wk Low
¥19.28

Chart for

About

China Meheco Co., Ltd. is mainly engaged in the operation of industrial pharmaceutical, commercial pharmaceutical and international trading businesses. Industrial Pharmaceutical segment mainly involves in the manufacture and distribution of chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine,... (more)

Overall

Beta: 1.00
Market Cap(Mil.): ¥23,325.04
Shares Outstanding(Mil.): 1,068.48
Dividend: 0.27
Yield (%): 1.22

Financials

  Industry Sector
P/E (TTM): -- 31.22 16.52
EPS (TTM): -- -- --
ROI: -- 14.09 36.19
ROE: -- 15.56 17.38

BRIEF-China Meheco Sells 7.2 Million Shares In China Merchants Bank As Of Dec

* SAYS IT HAS SOLD 7.2 MILLION SHARES IN CHINA MERCHANTS BANK AS OF DEC, RECEIVES NET INVESTMENT PROFIT OF ABOUT 128 MILLION YUAN ($19.66 million) Source text in Chinese: http://bit.ly/2C7C4qp Further company coverage: ($1 = 6.5100 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Dec 29 2017

BRIEF-China Meheco unit to set up pharmaceutical commerce JV in Hubei

* Says co's Hubei-based pharmaceutical unit plans to invest 5.1 million yuan to set up a Hubei-based pharmaceutical commerce JV, with registered capital of 10 million yuan

Dec 19 2017

BRIEF-China Meheco unit to invest 5.1 mln yuan to set up hematodialysis JV in Guangdong

* Says Guangdong-based medicine unit will invest 5.1 million yuan to set up a hematodialysis JV in Guangdong and hold 51 percent stake in the JV after transaction

Dec 15 2017

BRIEF-China Meheco says change of corporate auditor

* Says it plans to name Grant Thornton as corporate auditor for 2017

Oct 30 2017

BRIEF-Pharmaceutical firm China Meheco's board elects chairman

Oct 9 China Meheco Co Ltd * Says board elects Jiang Xin as chairman Source text in Chinese: http://bit.ly/2hYjY0W Further company coverage: (Reporting by Hong Kong newsroom)

Oct 09 2017

BRIEF-China Meheco unit gets approval for drug clinical trials

* Says its unit received drug clinical trials approval for its injection, which is mainly used for treatment of lung cancer and breast cancer

Sep 20 2017

BRIEF-China Meheco's H1 net profit up 28.05 pct y/y at 652.65 mln yuan

* Says H1 net profit up 28.05 percent y/y at 652.65 million yuan ($97.94 million)

Aug 25 2017

Earnings vs. Estimates